Chair, Nathan A. Pennell, MD, PhD, FASCO, and Laura J. Tafe, MD, discuss NSCLC in this CME/MOC/CC/NCPD/CPE/IPCE activity titled “Fine-Tuning Biomarker Testing to Identify and Target RET Fusions as Uncommon But Actionable Genomic Alterations in NSCLC.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CC/NCPD/CPE/IPCE information, and to apply for credit, please visit us at https://bit.ly/3fwhuok. CME/MOC/CC/NCPD/CPE/IPCE credit will be available until January 29, 2024.
